Myotonia Congenita
Int.
J. Pharm. Sci. Rev. Res., 61(1), March - April 2020; Article No. 11, Pages:
65-66
ISSN 0976 – 044X
MD Arif Khan1, Dr. Om Prakash2
1Department
of Pharmacy Practice, Balaji Institute of Pharmaceutical Sciences, Narsampet,
Warangal, Telangana, India.
2Sri Sri
Neuro Center, Hanamkonda, Warangal, Telangana-India.
*Corresponding author’s E-mail: arif7702456790@gmail.com
Received: 08-01-2020; Revised: 22-02-2020; Accepted: 28-02-2020.
INTRODUCTION
M
|
birth. Actually it is a rare
and genetically yo: Muscle,
Tonia: Tension Congenital: defect by
heterogeneous syndrome. In clinical myotonia is
failure of muscle relaxation after contraction of muscle1.
Electrical myotonia is spontaneous discharge of muscle fibres which increase or
decrease in both frequency and amplitude on electromyography (EMG)2.
Drugs like cholesterol lowering agents, cyclosporine, and others, in pompe
disease inflammatory myopathies leads to electrical myotonia1.
Clinical myotonia symptoms like painless muscle stiffness and some are with
pain2. The location of stiffness depends upon the disorder but
mainly seen in parts of eyelids, mouth, hands, and proximal legs35,
cold, stress, and exercise, and symptoms worse during pregnancy and
menstruation3. Mytonia can be revealed by fallowing method, by
asking the patient to grip and relax their arm and blinking of their eyes6.
Myotonia can be classified into dystrophic or non
dystrophic. it is characterized by fixed weakness, dystrophic changes on muscle biopsy, and fixed weakness and
dystrophic changes are less common in non dystrophic myotionias (NDM)7.
Recent studies reveal that structural muscle changes on magnetic resonance
imaging and ultrasound imaging of some patient8-9.
CASE REPORT
The subject name was xxx 6yrs old boy, the subject
joined in the hospital with these clinical futures like difficulty in getting
up from sitting position, holding of object is hard with both hands, muscle
stiffness, hyperhydrosis were observed in patient.
Medical examination results in goiter (+), deep tendon
reflex, hypertrophied muscle.
Lab investigation
Reviewed that serum electrolytes were normal, serum creatine phosphokinase was observed to be 184 U/L
Treatment
Acetazolimide (it is a carbonic and hydrase inhibitor,
it inhibit accumulation of carbonic acid.) carbamazepine (It is a sodium
channel blocker, it binds preferentially to voltage –gated sodium channels in
their inactive conformation, which prevents repetitive and sustained firing of
an action potential) phenytoin (involve in voltage –dependent blockade of
membrane sodium channels resulting in a reduction in sustained high –frequency
neuronal discharges.) gabapentin (it was designed to mimic the neurotransmitter
GABA it doesn’t, however, bind to GABA receptors it involves in inhibition of
alpha2-delta subunit of voltage- gated calcium channels)
Genetic Counselling
Myotonia congentia may be autosonal recessive (Beckers
diseases) or an autosomal dominant (Thomsen diseases). In the individual with
autosomal dominant have50% chance of inheriting the pathogenic variant.
Autosomal recessive is 25% chance of being affected, a 50% of chance of being
an asymptomatic carrier, and nearly 25% of subject is being unaffected and not
a carrier. The molecular genetic testing reveals two pathogenic variants in
CLCN1. Molecular genetic testing is done in the case of high rate of
inheritance in the family.
DISCUSSION
MYOTONIC CONGENITA (MC)
It is also known as chloride chanalopathy, typically
dived into two types
1) Thomsen
diseases
2) Becker
diseases
Over 150 mutations in the CLCN1 gene have been
reported10.
In 1876 Thomsen was the first person who affected with
the Thomsen diseases, he described his own disability11.In first
decade it is mainly seen in legs more than arms, hands and face3,4,12.
Disease severity is widely in family but penetrance is incomplete13.
Worsen pain observed after rest and removal of is seen after slight movements.
Myotonia can also affect muscle of mastication and swallowing3,4.
Myotonia is more pronounced in hands than eyelids and percussion myotonia3,4.
Beckers is usually seen in between the age of 4 and 12
years, and onset in adulthood is also seen 11,12. Symptoms are
similar to the Thomsen diseases but myotonia tends appear more in lower limbs
and proximal muscle and men are more affected than women12. It last
for seconds to minutes, is sometimes
seen after sustained bouts of myotonia and patients often have difficulty
moving if startled suddenly4,11. It is similar to Thomsen disease ,
no symptomatic features, and lifespan is normal.
Laboratory investigation are normal in both in
dominant and recessive MC anyway mild elevation is ck can be seen11.electromyography
needle (EMG) shows wide spread of myotonic discharges and myotonic motor units
can be seen in weak muscles if it is not masked by myotonia. Genetic testing
and muscle biopsy are rarely done due commercial availability 11.
CONCLUSION
The myotonia disorder is a heterogeneous group of
diseases that result in clinical and electrical myotonia. In this case report
it is an autosomal recessive myotonia congenita caused by a heterogeneous
mutation in the in genotype of CLCN1 gene.
REFERENCES
1. A J Hudson,
G C Ebers, D E Bulman The Skeletal Muscle Sodium and Chloride Channel Disease
Review, Brain 118 (Pt2), Apr 1995, 547-63.
2. E Matthews,
D Fialho, S V Tan, S L Venance, S C Cannon, D Sternberg, B Fontaine, A A Amato,
R J Barohn, R C Griggs, M G Hanna, CINCH Investigators The Non-Dystrophic
Myotonias: Molecular Pathogenesis, Diagnosis and
Treatment
Brain. 133(1), 2010 Jan, 9–22.
3. Jaya R
Trivedi, Brian Bundy, Jeffrey Statland, Mohammad
Salajegheh,
Dipa Raja Rayan, Shannon L Venance, Yunxia Wang, Doreen Fialho, Emma Matthews,
James Cleland, Nina Gorham, Laura Herbelin, Stephen Cannon, Anthony Amato,
Robert C Griggs, Michael G Hanna, Richard J Barohn, CINCH Consortium
Non-dystrophic Myotonia: Prospective Study of Objective and Patient Reported
Outcomes, Multicenter Study, brain 136 (Pt 7), 2189-200 Jul 2013.
4. T M Miller,
M R Dias da Silva, H A Miller, H Kwiecinski, J R Mendell, R Tawil, P McManis, R
C Griggs, C Angelini, S Servidei, J Petajan, M C Dalakas, L P W Ranum, Y H Fu,
L J Ptácek Correlating Phenotype and Genotype in the Periodic
Paralyses>NEUROLOGY 63(9), 1647-55 2004 Nov 9.
5. J Trip, S
Pillen, C G Faber, B G M van Engelen, M J Zwarts, G Drost Muscle Ultrasound
Measurements and Functional Muscle Parameters in Non-Dystrophic Myotonias
Suggest Structural Muscle Changes July 2009Volume 19, Issue 7, Pages 462–467.
6. Jasper M
Morrow, Emma Matthews, Dipa L Raja Rayan, Arne Fischmann, Christopher D J
Sinclair, Mary M Reilly, John S Thornton, Michael G Hanna, Tarek A Yousry
Muscle MRI
Reveals
Distinct Abnormalities in Genetically Proven NonDystrophic Myotonias>
Neuromuscul Disord 23 (8), 637-46 Aug
2013.
7. Morten Dunø,
Eskild Colding-Jørgensen 2 Margaret P Adam, Holly H
Ardinger, Roberta A Pagon, Stephanie E Wallace, Lora JH Bean, Karen Stephens,
Anne Amemiya Myotonia Congenita In: GeneReviews® [Internet]. Seattle
(WA): University of Washington, Seattle; 1993–2019.2005 Aug 3 [updated 2015 Aug
6].
8. E
Plassart-Schiess, A Gervais, B Eymard, A Lagueny, J Pouget, J M Warter, M
Fardeau, T J Jentsch, B Fontaine]. Novel Muscle Chloride Channel (CLCN1)
Mutations in Myotonia Congenita With Various Modes of Inheritance Including
Incomplete Dominance and Penetrance
>Neurology,
50(4), 1176-9 Apr 1998.
9. Eskild
Colding-Jørgensen, Phenotypic Variability in Myotonia Congenita Review,
>Muscle Nerve, 32 (1), 19-34 Jul 2005.
10. E Kuhn, W
Fiehn, D Seiler, J M Schröder The Autosomal Recessive (Becker) Form of Myotonia
Congenita
Review>Muscle
Nerve, 2 (2), 109-17 Mar-Apr 1979.
11. J Trip, G
Drost, H B Ginjaar, F H M Nieman, A J van der Kooi, M de Visser, B G M van
Engelen, C G Faber Redefining the Clinical Phenotypes of Non-Dystrophic
Myotonic Syndromes J neurol Neurosurg psychiarty80 (6), 647-52 Jun 2009.
12. David C.
Preston, Barbara Shapiro Electromyography and Neuromuscular Disorders: Clinical
Electrophysiologic Correlations Reviewed by Paul S. Giacomini2006 Jul; 9(2):
173.
13. Linda L.
Bachinski, Bjarne Udd, Giovanni Meola, Valeria Sansone, Guillaume Bassez, Bruno
Eymard, Charles A. Thornton, Richard T. Moxley, Peter S. Harper,
Mark T. Rogers, Karin Jurkat-Rott, Frank Lehmann-Horn, Thomas Wieser, Josep
Gamez, Carmen Navarro, Armand Bottani, Andre
Kohler,
Mark D. Shriver, Riitta Sallinen, Maija Wessman,
Shanxiang Zhang,
Fred A.
Wright, and Ralf Krahe,
Confirmation
of the Type 2 Myotonic Dystrophy (CCTG)n
Expansion Mutation in Patients with Proximal Myotonic Myopathy/Proximal
Myotonic Dystrophy of Different European Origins: A Single Shared Haplotype
Indicates an Ancestral Founder Effect Multicenter study>AM J HUM genet
Comments